Dr. Paul Leeson
Member
Advisory Council
Inflazome
Ireland
Biography
\Paul Leeson is a medicinal chemistry consultant with >35 years’ experience in major pharmaceutical companies: Smith Kline and French, Merck Sharp and Dohme, Wyeth (USA), AstraZeneca, and GlaxoSmithKline. Since 2014 he has advised large and small pharmaceutical companies, start-ups, and academia. At AstraZeneca (1997-2011), Paul was head of medicinal chemistry at the Charnwood site, where his Department invented >40 candidate drugs, with one marketed. He led AstraZeneca’s Global Chemistry Forum, which managed global activities and implemented improved practices in hit-to-lead, lead optimisation, prediction, synthesis and outsourced chemistry. Paul’s drug discovery contributions have been in the cardiovascular, neuroscience, respiratory and inflammation therapy areas. He has a special interest in compound quality, recognised in 2014 by the receipt of the Nauta Award from the European Federation of Medicinal Chemistry. Paul has a PhD from the University of Cambridge and holds an honorary professorship at the University of Nottingham.
Research Interest
product development , biotechnology , Business management